FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization by Yuan, Hsiang-Yu et al.
FASTSNP: an always up-to-date and extendable
service for SNP function analysis and prioritization
Hsiang-Yu Yuan
1, Jen-Jie Chiou
2, Wen-Hsien Tseng
2, Chia-Hung Liu
2, Chuan-Kun Liu
3,
Yi-Jung Lin
3, Hui-Hung Wang
1, Adam Yao
1,3, Yuan-Tsong Chen
1 and Chun-Nan Hsu
2,*
1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan,
2Institute of Information Science,
Academia Sinica, Taipei, Taiwan and
3National Genotyping Center, Academia Sinica, Taipei, Taiwan
Received February 15, 2006; Revised March 8, 2006; Accepted March 28, 2006
ABSTRACT
Single nucleotide polymorphism (SNP) prioritization
based on the phenotypic risk is essential for asso-
ciation studies. Assessment of the risk requires
access to a variety of heterogeneous biological
databases and analytical tools. FASTSNP (function
analysis and selection tool for single nucleotide
polymorphisms) is a web server that allows users
to efficiently identify and prioritize high-risk SNPs
according to their phenotypic risks and putative
functional effects. A unique feature of FASTSNP
is that the functional effect information used for
SNP prioritization is always up-to-date, because
FASTSNP extracts the information from 11 external
webserversatquerytimeusingateamofwebwrapper
agents. Moreover, FASTSNP is extendable by simply
deploying more Web wrapper agents. To validate the
results of our prioritization, we analyzed 1569 SNPs
from the SNP500Cancer database. The results show
that SNPs with a high predicted risk exhibit low allele
frequencies for the minor alleles, consistent with a
well-known finding that a strong selective pressure
exists for functional polymorphisms. We have been
using FASTSNP for 2 years and FASTSNP enables
us to discover a novel promoter polymorphism.
FASTSNP is available at http://fastsnp.ibms.sinica.
edu.tw.
INTRODUCTION
An important approach to disease gene mapping is investi-
gating whether a single nucleotide polymorphism (SNP) is
functionally involved in a disease. For complex diseases,
the problem is complicated because, unlike Mendelian dis-
eases, their genetic causes might involve many genes and
hundreds of alleles. Although there are millions of SNPs
deposited in public SNP databases, only a small proportion
of them are functional polymorphisms that contribute to
disease phenotypes. Thus, prioritizing SNPs based on their
phenotypic risks is essential for association studies (1).
Assessment of the risk requires access to a variety of
heterogeneous biological databases and analytical tools.
FASTSNP (function analysis and selection tool for single
nucleotide polymorphisms) is a web server that allows users
to efﬁciently identify the SNPs most likely to have functional
effects. It prioritizes SNPs according to 13 phenotypic risks
and putative functional effects, such as changes to the tran-
scriptional level, pre-mRNA splicing, protein structure and
so on. A unique feature of FASTSNP is that the prediction
of functional effects is always based on the most up-to-date
information, which FASTSNP extracts from 11 external web
servers at query time using a team of re-conﬁgurable web
wrapper agents (2,3). These web wrapper agents automate
web browsing and data extraction and can be easily conﬁgured
and maintained with a tool that uses a machine learning algo-
rithm. This allows users to conﬁgure/repair a web wrapper
agent without programming. Another beneﬁt of using web
wrapper agents is that FASTSNP is extendable, so we can
include new functions by simply deploying more web wrapper
agents. In this manner, we have already built several new
functionalities, such as the inclusion of information on
haplotype blocks from HapMap (4).
SNP prioritization
Recent studies show that SNPs may have functional effects
on the following.
(i) protein structures, by changing single amino acids (5,6);
(ii) transcriptional regulation, by affecting transcription
factor binding sites in promoter or intronic enhancer
regions (7,8); and
(iii) alternative splicing regulation, by disrupting exonic
splicing enhancers (9) or silencers.
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(non-sense), which would disable the protein function. Each of
these distinct functional effects may incur a risk that causes a
disease. Therefore, to prioritize SNPs for the study of complex
diseases, it is critical to identify the functional variants that
are most likely to have functional effects leading to disease
phenotypes before genotyping. Based on previous studies of
the functional effects of polymorphisms, Tabor et al. (1)
presented a prioritization strategy that associates the relative
risk of a SNP with its location and the type of sequence vari-
ants. We extended their strategy with our recent ﬁndings and
developed a decision tree to assess the risk of a SNP. The
decision tree, shown in Figure 1, classiﬁes a SNP into 1 of
13 types of the functional effects, each of which is assigned a
risk ranking number between 0 and 5. A high risk rank implies
a high-risk level. Table 1 gives the deﬁnitions of the function
types, effects and their predicted risk ranking.
For a coding SNP, if it is non-synonymous and alters an
amino acid in a proteinresulting in a different protein structure
(mis-sense, non-conservative change), or a non-sense change
that results in a premature termination of the amino acid
sequence (non-sense), then it will be assigned a high-risk or
very high-risk ranking, because most known disease-causing
SNPs are in these classes. A non-synonymous SNP that alters
an amino acid in a protein to one with similar structural
characteristics will be classiﬁed as ‘mis-sense, conservative
change’ with a moderate risk ranking.
A coding SNP, be it synonymous or non-synonymous, may
disturb the binding sites of an exonic splicing enhancer or
silencer.In thiscase,the SNP may regulate alternative splicing
and will be classiﬁed as ‘splicing regulation.’ If the alternative
splicing further abolishes a domain of the translated protein
due to exon skipping, then we classify such a SNP as ‘splicing
regulation, abolishingproteindomain’ and assign it a high-risk
ranking. A ‘sense/synonymous’ SNP that does not affect any
motif or protein structure will be assigned a low-risk ranking.
For a non-coding SNP, if its location is in the downstream
region, it is unlikely that it has any functional effect. We
classify this type of SNP as ‘downstream with no known
function’ and assign no risk to it. However, if the transcription
factor-binding site of the gene is changed by this polymorph-
ism in the promoter region, then this SNP may affect the level,
location, or timing of gene expression. In this case, it will be
classiﬁed as ‘promoter/regulatory region’ with a low or mod-
erate risk ranking; otherwise, it will be classiﬁed as ‘upstream
with no known function.’ If it is in the intronic region, it
may alter a binding site of the transcription factor and will
be classiﬁed as ‘intronic enhancer’ with a low-risk ranking.
A SNP at the ‘splicing site’ may break the consensus splicing
site sequence and will thus be assigned a high-risk ranking.
A SNP at an untranslated region (UTR) of a sequence will
be classiﬁed as ‘Untranslated’ with no risk. Recently, a new
function type ‘30-UTR post-transcriptional regulation’ was
reported (10), but its actual phenotypic risk is still under-
determined. Since we have no substantial evidence about its
risk, we will assign such a SNP a moderate-risk ranking.
Consequently, our decision tree is complete in the sense
that it considers all known functional roles of a SNP in a gene.
Figure 1. DecisiontreeforprioritizingaSNPbasedonitsfunctionaleffects.Thediamondsrepresentdecisionpointsandtheovalsrepresentterminalpointswiththe
risk and class assignments. Given an input SNP at a decision point, if the answer to the question in the diamond is ‘yes,’ then the vertical arrow should be followed.
Otherwise, the horizontal arrow should be followed.
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and effect on a gene, Tabor et al. (1) further suggested ﬁltering
high-priority SNPs based on their allele frequencies, and using
haplotype information to select a single SNP for genotyping if
several SNPs are known to be in linkage disequilibrium.
Though FASTSNP does not currently integrate this type of
information in the prioritization method, it does provide their
haplotype information in the output function report.
Web wrapper agents
The information required to answer the questions about the
13 decision points in the decision tree is available; however, it
is spread over a variety of online sequence databases and
analytical tools. Table 2 presents the databases and analytical
tools used by FASTSNP for SNP prioritization and other func-
tions. A traditional approach to integrating external sources is
to download all the required data and programs and implement
a huge data warehouse, but this often runs into maintenance
difﬁculties because all the data must be kept up-to-date (11).
FASTSNP applies web wrapper agents (2,3) to resolve this
problem. A web wrapper agent is a script that deﬁnes a user
browsing session. When executed, the agent will visit the
target website, ﬁll in the query forms, extract the returned
data and perform other web interactions to complete the
user browsing session. Since FASTSNP uses the agent to
access the external web servers at query time, the information
used to prioritize SNPs is always the most up-to-date informa-
tion available.
Web wrappers, however, are notorious for their fragility,
because the format of web pages usually changes without
notice. Previously, we developed a Java program, called
Agent Toolbox, to cope with this issue (2). Agent Toolbox
allows a user to produce an agent in a programming-
by-example manner. More precisely, to produce an agent,
the user simply browses the target website using the browser
embedded in the user interface of Agent Toolbox to provide an
example of a user session, and Agent Toolbox will generalize
the example into a script that describes the user session.
Agent Toolbox can also generate data extraction rules to
parse a given web page. Again, there is no need for users to
program the data extraction rules. Instead, Agent Toolbox
‘learns’ these rules from users’ labels on the web page with
a machine learning algorithm (12,13). As a result, we can
Table 1. Definitions of the function types, their effects and predicted risks of SNPs
Coding type Function type Possible effects Risk (ranking)
Coding Non-sense Causes premature termination of an amino-acid sequence Very high (5)
Splicing regulation (abolishing
protein domain)
Breaks the exonic splicing enhancer/silencer binding site in
a coding sequence, leading to abolished protein domain
Moderate to high (3 4)
Splicing regulation Breaks the exonic splicing enhancer/silencer binding site in
a coding sequence containing the same protein domains
Low to moderate (2 3)
Mis-sense (non-conservative change) Alters an amino acid in a protein to one with different
structure characteristics
Moderate to high (3 4)
Mis-sense (conservative change) Alters an amino acid in a protein to one with similar
structure characteristics
Low to moderate (2 3)
Sense/synonymous Does not alter an amino acid in a sequence Very low (1)
Non-coding Downstream with no known effect No known effect No known effect (0)
Upstream with no known effect No known effect No known effect (0)
Splicing site Breaks a consensus splicing site sequence Moderate to high (3 4)
Promoter/regulatory region Does not alter an amino acid, but can affect the level,
location or timing of a gene expression
Very low to moderate (1 3)
Intronic enhancer Alters a binding site of a transcription factor in an intronic region Very low to low (1 2)
Untranslated Changes an UTR in a sequence No known effect to very low (0 1)
30utr post-transcriptional regulation Breaksmotifslikelytobeinvolvedinpost-transcriptionalregulation Very low to moderate (1 3)
Table 2. External web-based services accessed by FASTSNP
Name/URL Usage
NCBI dbSNP (www.ncbi.nlm.nih.gov/SNP) Provides the location of a SNP in a gene and its alleles, allele frequency, and context sequence
Ensembl (www.ensembl.org) Provides a cross-reference/alternative data source for dbSNP
TFSearch (www.cbrc.jp/research/db/TFSEARCH.html) Predicts if a non-coding SNP alters the transcription factor-binding site of a gene
PolyPhen (www.bork.embl-heidelberg.de/PolyPhen) Predicts if a non-synonymous SNP alters an amino acid in a protein resulting in structural changes
(damaged or benign) in a protein
ESEfinder (rulai.cshl.edu/ESE) PredictsifasynonymousSNPislocatedinaexonicsplicingenhancermotif,whichwoulddiminish
the motif with a different allele
RescueESE (genes.mit.edu/burgelab/rescue-ese) Provides a cross-reference/alternative data source for ESEfinder
FAS-ESS (genes.mit.edu/fas-ess/) Predicts exonic splicing silencer for each SNP allele
SwissProt (us.expasy.org/sprot) ProvidestheinformationaboutproteindomainstodetermineifaSNPcausesanalternativesplicing
that leads to a protein domain being abolished
UCSC Golden Path (genome.ucsc.edu) Provides information about the final draft assembly of the genome sequence (i.e. Golden Path) for
quality control of candidate SNPs
NCBI Blast (www.ncbi.nlm.nih.gov/BLAST) Sequence comparison and search tool for quality control of candidate SNPs
HapMap (www.hapmap.org) Provides information about the haplotype and linkage disequilibrium around a SNP
The first eight services provide databases and analytical tools to predict functional effects for SNP prioritization. UCSC Golden Path and NCBI Blast are used for
quality control of candidate SNPs, while the haplotype database from HapMap is useful for further reducing the number of candidate genes for genotyping.
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Toolbox also enables FASTSNP to be extended, so new func-
tionalities can be included by deploying more web wrapper
agents. For example, haplotype information is a new function
that we included recently by producing an agent to access
HapMap (4). Currently, a total of 11 agents are deployed
by FASTSNP. A detailed explanation of how Agent Toolbox
works is beyond the scope of this paper. For the most recent
report, please refer to Ref. (2).
User interface
FASTSNP is available at http://fastsnp.ibms.sinica.edu.tw.
Users can choose from three different methods to specify
their SNPs as the input to query FASTSNP. The main
query method is ‘Query by Candidate Gene.’ The user can
choose to specify a gene symbol, SNP reference cluster ID
(rsid), or a chromosome position as the query. Since the func-
tional effects of an SNP may be different in different tran-
scripts of the gene, FASTSNP will provide the transcripts of
the queried gene for users to select before it outputs the set
of SNPs on the queried gene. The user further reﬁnes the set of
SNPs by specifying the region whether the SNPs are coding
or non-coding and the allele frequency. After a ﬁnal set of
candidate SNPs is selected, FASTSNP will perform the SNP
prioritization described earlier, return the prioritization results
in a risk ranking report, and provide a function report for each
candidate SNP. FASTSNP also provides ‘Query by SNP’
which allows the user to specify a single SNP rs ID or upload
an Excel ﬁle containing their entire candidate SNPs for
prioritization. Finally, FASTSNP also accepts novel SNP
sequences as input. The user may paste a ‘novel SNP’
sequence in the text area and specify the position and the
substitution via FASTSNP’s web interface.
The function report on a SNP contains seven sections on the
SNP’s functional effects, namely (i) genomic information,
presents the nearby sequence, the alleles and the allele fre-
quency among different ethnic groups; (ii) functional effects
summary, presents the risk assessment; (iii) transcription reg-
ulatory, shows the predicted transcription factor binding sites
generated or disrupted by the different SNP alleles; (iv) alter-
native splicing regulatory, reports exonic splicing enhancer/
silencer motifs changed by the SNP alleles leading to exon
skipping or inclusion; (v) mRNA/protein domain effects, pre-
sents all spliced forms of mRNAs and protein variants
extracted from GenBank (14). The protein domains that the
SNP locates in are highlighted; (vi) protein structure effects,
reports whether the SNP may cause a signiﬁcant structural
change in a protein; and (vii) SwissProt (15) feature table,
provides information regardingotherknownmutationsorvari-
ations of the translated protein of mRNAs related to the SNP.
Some of these sections are speciﬁc to coding or non-coding
SNPs and they will appear or not appear in the function report
accordingly.
Implementation
FASTSNP is written in Java and its web interface application
is written in Java Server Pages (JSP). It runs on top of the
Linux operating system and Tomcat web server and uses the
MySQL database management system as its storage platform.
Web wrapper agents are encapsulated as JavaBeans. Figure 2
Figure 2. FastSNP component modules and data flow. Each gray box represents an external web server accessed by a web wrapper agent, and each blue box
represents a local Java program. Open boxes are data and the arrows represent the data flow.
W638 Nucleic Acids Research, 2006, Vol. 34, Web Server issueshows the data ﬂow diagram of the four major component
modules in FASTSNP: (i) Query module, (ii) Function ana-
lysis module, (iii) Prioritization module and (iv) Function
report module.
The system will start at different modules when the user
queries FASTSNP in different ways. When the user queries
FASTSNP by gene, the query module will be used to check a
cross-reference table and convert the query term to Ensembl
Gene Name (16). The cross-reference table combines a set of
widely used gene nomenclatures, including HUGO Gene
Symbol,HUGOGeneAliases(17),NCBIReferenceSequence
(RefSeq) (18) and SwissProt Entry Name and users can query
FASTSNP with these gene nomenclatures. With the converted
gene name, we can extract a set of SNPs on the queried gene
from the EnsemblMart database.
Given a set of SNPs, FASTSNP will dispatch the dbSNP
agent to query dbSNP (19) for their genomic context
sequences, their mRNA reference sequences (RefSeq), and
their relative locations in gene sequences (e.g. 50 upstream,
50-UTR, non-synonymous, intronic and so on). Next,
FASTSNP will prepare a set of sequences for each SNP as
the input of the function analysis module. Each sequence is a
41 bp fragment trimmed from the genome sequence with the
SNP allele exactly in the middle.
The function analysis module consists of three agent pipe-
lines corresponding to decision paths in the decision tree
shown in Figure 1. The ﬁrst pipeline is for non-coding
SNPs. The input sequence pair will be sent to TFSearch
(20) to obtain the predicted transcription factor-binding
sites. The second pipeline handles non-synonymous SNPs.
In this pipeline, an agent will query PolyPhen (21) to obtain
its prediction on whether the SNP will alter an amino acid in a
protein and result in structural changes (damaged or benign) in
the protein. The third agent pipeline obtains information to
predict ifthealternative splicingcausedbyasynonymousSNP
may abolish a protein domain. FASTSNP will ﬁrst invoke the
agents for ESEﬁnder (22), RESCUE-ESE (23) and FAS-ESS
(24) to predict if the SNP is located in an exonic splicing
enhancer or silencer motif. It then invokes another agent to
query Ensembl Protein Report (16) and obtain all known alter-
native spliced-form mRNAs for the gene where the SNP is
located. With the spliced form mRNAs, the agent for
SwissProt (15) will be able to extract the data about the trans-
lated proteins of the mRNAs to determine if the SNP leads to
an alternative splicing that abolishes a protein domain.
FASTSNP will perform the necessary post-processing for
the data returned from the agent pipelines and submit the
results to the prioritization module, which will then classify
the SNP, assign it a risk ranking according to the decision tree
shown in Figure 1, and compile the results into a function
report.
In public domain databases, many SNPs are mapped to
different positions in the human genome. Therefore in the
function report, we provide buttons for users to invoke agents
to check the sequence quality of SNPs and verify that a SNP
uniquely maps to one position in the human genome. One of
these agents maps the SNP on the UCSC Golden Path (25)
sequence and integrates both NCBI and Ensembl annotations.
FASTSNP also uses NCBI BLAST (26) to search the UCSC
Golden Path to extend the SNP sequence to 500 base-pairs.
We do this because a SNP’s sequence in public domain
databases is usually too short to allow the design of good
quality primers.
FASTSNP also provides haplotype data, which is obtained
from the HapMap (4). With haplotype information, we only
need to select a minimum number of SNPs as markers (also
known as tagSNPs) among the SNPs in linkage disequilibrium
to conduct our association study. This reduces genotyping
costs signiﬁcantly.
Related works
Public domain SNP databases, such as dbSNP (19) and widely
used SNP searching tools such as SNPper (27) contain well-
organized catalogs of SNPs and provide entry portals to search
for fundamental information about SNPs. However, searching
for the information necessary to prioritize SNPs requires spe-
cialized Web servers, such as PupaSNP Finder (28), Wjst’s
system (29), PolyMAPr (30) and SNPselector (31). These
servers usually integrate information from a variety of data-
bases and analytical tools.
FASTSNP differs from the above systems in many respects.
First,itusesacompletedecisiontreetoassignriskrankingsfor
SNP prioritization. It also considers some novel functional
effects not considered by previous works, including the aboli-
tion of a protein domain due to exon skipping and the stability
of a protein’s structure. Another key feature of FASTSNP is
that it applies web wrapper agents to query external sources at
query time. As a result, it is highly extendable. Moreover, it
always provides prioritization based on the most up-to-date
information, thereby allowing users to update their queries. A
recently published system called Galaxy (32) also aims at
accomplishing this task. Their system provides up-to-date
information by providing interactive communication to exter-
nal websites to answer user queries.
Validation
A well-known ﬁnding of functional polymorphisms is that
they are usually under strong selective pressure and thus
have low minor allele frequencies (5). To validate the results
of our prioritization, we compared the output risk rankings of
FASTSNP with the allele frequencies from SNP500Cancer
(33) to see if SNPs with high predicted risks actually have
low allele frequencies. The SNP500Cancer database was
selected because it provides sufﬁcient curated disease-causing
SNPs with comparable allele-frequency results obtained by
sequencing the same 102 subjects of different ethnic groups.
FASTSNP successfully prioritized 1569 SNPs and the results,
asgiveninFigure3,showthathigh-riskSNPs tendtohave low
allele frequencies. SNPs with the highest risk have the least
mean minor allele frequency (MAF) and MAF increases if the
risk is not as high, consistent with Cargill et al.’s ﬁnding (5).
RESULTS AND DISCUSSION
FASTSNPallows usersto select functional polymorphisms for
association studies in a convenient way. The National
Genotyping Center (NGC) in Taiwan has been using this
system to manage 5000 candidate SNPs and has already
obtained their genotyping results using the MALDI-TOF
high-throughput genotyping system. One of the most intensely
researched topics at NGC is determining candidate genetic
Nucleic Acids Research, 2006, Vol. 34, Web Server issue W639variants that contribute to adverse drug responses for different
ethnic populations. Discovering major genetic factors that
contribute to individual reactions to a certain medication
may help to control and prevent side-effects or over dose
during therapy, thereby avoiding serious consequences.
With FASTSNP, the research team at NGC recently discov-
ered a novel promoter polymorphism associated with the dif-
ferent therapeutic dosage of a drug (34). This polymorphism is
predicted to change Ebox-binding site.
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